“…Suscep¬ tibility of older children and adults to infection with pertussis and their role in its transmission to younger, susceptible persons have been documented else¬ where.1316 These findings underscore the need to consider alternative control measures, such as the use of erythro¬ mycin when confronted with an outbreak of pertussis, particularly in view of high secondary attack rates (80% to 100%) among susceptible contacts. 3,5,6,17,18 While there are no data from controlled clinical trials demonstrating that prompt initiation of erythromycin treatment in the patient with a primary case will result in decreased transmission to close contacts, the efficacy of this measure is supported by observational data from our study and others. Steketee et al,17 in an institutional set¬ ting, found that infected persons with cough symptoms had shorter cough duration if treated with erythromycin within 1 week of illness onset, consistent with the findings of other studies.11,13,19,20 Biellik et al,10,21 in two separate investigations, found a delay in initiating eryth¬ romycin treatment among patients with primary cases in households with secondary transmission.…”